Anti-TNF Therapy in Juvenile Idiopathic Arthritis

Czech version

Authors: J. Hoza
Authors‘ workplace: Klinika dětského a dorostového lékařství UK 1. LF a VFN, Praha přednosta prof. MUDr. J. Zeman, DrSc.
Published in: Čes-slov Pediat 2008; 63 (12): 693-696.
Category: Actual Topic

Sources

1. Lovell DJ, Reiff A, Ilowite NT, et al. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2008;5: 1496–1504.

2. Ilowite NT. Update on biologics in juvenile idiopathic arthritis. Curr. Opin. Rheumatol. 2008;20(5): 613–618.

Labels

Neonatology Paediatrics General practitioner for children and adolescents

Results of Treatment of Neonatal Hydronephrosis

Bone Mineral Density in Cystic Fibrosis Patients – Results of a 3-years Folow-up and Intervention

Prevalence and Risk Factors of Allergic Diseases in Preschool Children from Industrial and Rural Region of Slovak Republic

Clinical Manifestations and Results of Laboratory Examinations in Four Patients with Alpha-Mannosidosis

The Problem of HIV/AIDS in Pediatrics

Article was published in

Czech-Slovak Pediatrics

2008 Issue 12